HPV Vaccines

IDWeek 2013: HIV+ Young Women Have Adequate Response to Human Papillomavirus Vaccine

HIV positive girls did not respond as well to the quadrivalent human papillomavirus (HPV) vaccine as HIV negative girls of the same age, but they responded as well as HIV negative older women, probably giving them sufficient protection from infection, according to a late-breaker presentation at the recent IDWeek conference in San Francisco.

alt

Read more:

IDWeek 2013: Low-income Girls Are Less Likely to Receive Full HPV Vaccine Series

altLow-income adolescents are not as likely to start or finish the 3-shot human papillomavirus (HPV) vaccine series, which reduces the risk of cervical cancer. Cultural differences can help explain some of the reasons for this disparity and suggest targeted approaches for encouraging vaccination, researchers reported at Second IDWeek conference this week in San Francisco.

Read more:

IAS 2013: HPV Vaccination May Prevent Anal Cancer in Older Gay Men

A large number of infections with anal cancer-associated strains of human papillomavirus (HPV) among older gay men could be prevented with the use of HPV vaccines, Australian research reported at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur. A related analysis showed that high-grade pre-cancerous cell changes were common but often resolved spontaneously.

alt

Read more:

HPV Vaccine Prevents Oral Infection, May Lower Risk of Mouth and Throat Cancer

Vaccination against human papillomavirus (HPV) types 16 and 18 reduced oral infection by more than 90% in a large study in Costa Rica, which is likely to bring down the rate of mouth and throat cancers in years to come, according to a report in the July 17, 2013, online edition of PLoS ONE.

alt

Read more:

Lower HPV Prevalence Among Young Women Credited to Vaccine

The prevalence of human papillomavirus (HPV) among teenage women in the U.S. has declined substantially in recent years -- falling by more than 50% -- coinciding with widespread HPV immunization starting in 2006, according to a CDC study described in the June 19, 2013, advance edition of the Journal of Infectious Diseases.

alt

Read more: